IL1B and Hyperglycemia: Myricitrin can repair abnormal expression of mRNA IL1β, STAT1b and IκBα in diabetes disorder, thus mainly interfered with toll-like receptor pathway to promote glucose uptake and relieve hyperglycemia level in vivo.